PTEN and neoplasm: In particular, established M14-derived (PTEN-competent) or C32-derived (PTEN-loss) xenografts were treated with Trametinib and Everolimus, alone or in combination, for up to 13 days and the effects on tumor growth were evaluated at the point of maximum tumor inhibition.